• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Community Health Systems Inc.

    7/24/25 5:03:02 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care
    Get the next $CYH alert in real time by email
    S-8 1 cyh-20250724.htm S-8 S-8

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549
    __________________

    FORM S-8
    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

    __________________

    COMMUNITY HEALTH SYSTEMS, INC.
    (Exact name of registrant as specified in its charter)

    Delaware
    (State or other jurisdiction of
    incorporation or organization)

    13-3893191
    (
    IRS Employer
    Identification No.)

    __________________

    4000 Meridian Boulevard
    Franklin, Tennessee 37067
    (Address, including zip code, of principal executive offices)

    __________________

    Community Health Systems, Inc. 2009 Stock Option and Award Plan

    (Full title of the plan)

    __________________

    Justin D. Pitt
    President and Chief Legal and Administrative Officer and Assistant Secretary

    Community Health Systems, Inc.
    4000 Meridian Boulevard
    Franklin, Tennessee 37067
    (615) 465-7000

    (Name, address and telephone number, including area code, of agent for service)

    __________________

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

    Large accelerated filer o

    Accelerated filer þ

    Non-accelerated filer o

    Smaller reporting company o

     

    Emerging growth company o

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o

     


     

     

     

    EXPLANATORY NOTE

    This Registration Statement is being filed pursuant to General Instruction E of Form S-8 for the purpose of registering an additional 7,000,000 shares of common stock, par value $0.01 per share (“Common Stock”), of Community Health Systems, Inc. (the “Registrant”) available for issuance pursuant to awards under the Community Health Systems, Inc. 2009 Stock Option and Award Plan, as amended and restated (the “Plan”).

    The Registrant previously registered shares of Common Stock under the Plan on Registration Statements on Form S-8 filed with the Securities and Exchange Commission on December 14, 2009 (Registration No. 333-163689), September 16, 2011 (Registration No. 333-176893), July 31, 2013 (Registration No. 333-190260), August 1, 2014 (Registration No. 333-197813), August 3, 2016 (Registration No. 333-212874), July 31, 2018 (Registration No. 333-226455), July 29, 2020 (Registration No. 333-240174), July 29, 2021 (Registration No. 333-258268) and August 3, 2023 (Registration No. 333-273663) (collectively, the “Previous Registration Statements”). As permitted by General Instruction E of Form S-8, the contents of the Previous Registration Statements, including all exhibits filed therewith or incorporated therein by reference, to the extent not otherwise amended or superseded by the contents hereof, are incorporated herein by reference.

     


     

    PART I

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    The Registrant has sent or given or will send or give documents containing the information specified by Part I of this Registration Statement to participants in the Plan to which this Registration Statement relates, as specified in Rule 428(b)(1) promulgated by the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”). The Registrant is not filing such documents with the Commission, but these documents constitute (along with the documents incorporated by reference into the Registration Statement pursuant to Item 3 of Part II hereof) a prospectus that meets the requirements of Section 10(a) of the Securities Act.

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3. Incorporation of Documents by Reference.

    The Commission allows us to “incorporate by reference” information into this Registration Statement, which means that we can disclose important information to you by referring you to another document filed separately with the Commission. The information incorporated by reference is considered to be part of this Registration Statement, and later information that we file with the Commission will automatically update this Registration Statement. We incorporate the following documents by reference:

    •
    our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Commission on February 19, 2025;
    •
    the portions of our Definitive Proxy Statement on Schedule 14A, filed with the Commission on April 3, 2025 that were incorporated by reference into Part III of our Annual Report on Form 10-K for the year ended December 31, 2024;
    •
    our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025, filed with the Commission on April 24, 2025, and our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025, filed with the Commission on July 24, 2025;
    •
    our Current Reports on Form 8-K filed on February 14, 2025, March 3, 2025, April 1, 2025, April 15, 2025, April 23, 2025 (filed under Item 8.01), April 23, 2025 (filed under Item 8.01), May 7, 2025, May 9, 2025, May 14, 2025, July 1, 2025, July 22, 2025 and July 23, 2025 (other than the portion of those documents not deemed to be filed); and
    •
    the description of our common stock contained in Exhibit 4.2 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the Commission on February 20, 2020, and as amended by any subsequent amendment or report filed for the purpose of updating such description.

    All documents filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), subsequent to the effective date of this Registration Statement, prior to the filing of a post-effective amendment to this Registration Statement indicating that all securities offered hereby have been sold or deregistering all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof from the date of filing of such documents; provided, however, that in no event will any information that is deemed furnished and not filed, including any information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K (including any related exhibits), be incorporated by reference into, or otherwise become a part of, this Registration Statement, unless otherwise incorporated by reference herein. Any statement contained in any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed to constitute a part of this Registration Statement, except as so modified or superseded.

    Item 4. Description of Securities.

    Not applicable.

    Item 5. Interests of Named Experts and Counsel.

    Not applicable.


    Item 6. Indemnification of Directors and Officers.

    Pursuant to authority conferred by Section 102(b)(7) of the General Corporation Law of the State of Delaware (the “DGCL”), Article SIXTH of the Registrant’s restated certificate of incorporation, as amended, eliminates the personal liability of the Registrant’s directors and officers to the Registrant or its stockholders for monetary damages for breach of fiduciary duty to the fullest extent permitted under the law of the State of Delaware, including the DGCL. Article SIXTH further provides that any future amendment to or repeal of its terms will not adversely affect any right or protection of any director or officer of the Registrant with respect to acts or omissions of such director or officer occurring prior to such repeal or amendment. Article SIXTH also incorporates any future amendments to Delaware law which further eliminate or limit the liability of directors or officers. For purposes of Article SIXTH, “officer” shall have the meaning provided in Section 102(b)(7) of the DGCL as the same exists or may hereafter be amended.

    In accordance with Section 145 of the DGCL, Article SEVENTH of the Registrant’s restated certificate of incorporation, as amended, and certain provisions of the Registrant’s amended and restated by-laws grant the Registrant’s directors and officers a right to indemnification for all expenses relating to civil, criminal, administrative or investigative procedures to which they are a party (i) by reason of the fact that they are or were directors or officers of the Registrant or (ii) by reason of the fact that, while they are or were directors or officers of the Registrant, they are or were serving at the request of the Registrant as directors or officers of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan. Section 5 of Article VI of the Registrant’s amended and restated by-laws further provides for advancement of expenses to such indemnified persons.

    Article VI, Section 8 of the Registrant’s amended and restated by-laws authorize the Registrant to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Registrant, or is or was serving at the request of the Registrant as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan, against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the Registrant would have the power to indemnify such person against such liability under the provisions of the Registrant’s amended and restated by-laws. The Registrant has obtained insurance policies insuring its directors and officers against certain liabilities.

    The Registrant has entered into Indemnification Agreements (the “Indemnification Agreements”) with its directors and executive officers. One of the purposes of the Indemnification Agreements is to attempt to specify the extent to which persons entitled to indemnification thereunder (the “Indemnitees”) may receive indemnification. Pursuant to the Indemnification Agreements, an Indemnitee is entitled to indemnification for claims arising out of or in connection with the service of Indemnitee as a director or officer of the Registrant or of an affiliate. In the case of an action or proceeding other than an action by or in the right of the Registrant, the Indemnification Agreements provide that Indemnitee is entitled to indemnification for claims relating to (i) the fact that Indemnitee is or was an officer or director of the Registrant or any other entity which Indemnitee is or was or will be serving at the request of the Registrant, or (ii) anything done or not done by Indemnitee in any such capacity. In the case of an action by or in the right of the Registrant, the Indemnification Agreements provide that Indemnitee is entitled to indemnification for claims relating to (i) the fact that Indemnitee is or was an officer or director of the Registrant or any affiliate or (ii) anything done or not done in such capacity. The Indemnification Agreements are in addition to and are not intended to limit any rights of indemnification which are available under the Registrant’s restated certificate of incorporation, as amended, or the Registrant’s amended and restated bylaws, or otherwise. In addition to the rights to indemnification specified therein, the Indemnification Agreements are intended to increase the certainty of receipt by the Indemnitee of the benefits to which he or she is entitled by providing specific procedures relating to indemnification.

    We believe that our restated certificate of incorporation and amended and restated by-laws and insurance are necessary to attract and retain qualified persons as directors and officers.

    The limitation of liability and indemnification provisions in our restated certificate of incorporation and amended and restated by-laws may discourage stockholders from bringing a lawsuit against directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful, might benefit us and other stockholders. Furthermore, a stockholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers as required or allowed by these indemnification provisions.

    Item 7. Exemption from Registration Claimed.

    Not applicable.

     


    Item 8. Exhibits.

     

    Exhibit No.

    Description

    4.1

    Form of Restated Certificate of Incorporation of Community Health Systems, Inc. (incorporated by reference to Exhibit 3.1 to Amendment No. 4 to Community Health Systems, Inc.’s Registration Statement on Form S-1/A filed June 8, 2000 (No. 333-31790)).

     

    4.2

    Certificate of Amendment to the Restated Certificate of Incorporation of Community Health Systems, Inc., dated May 18, 2010 (incorporated by reference to Exhibit 3.2 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 20, 2010 (No. 001-15925)).

     

    4.3

    Certificate of Amendment to the Restated Certificate of Incorporation of Community Health Systems, Inc., dated May 13, 2025 (incorporated by reference to Exhibit 3.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 14, 2025 (No. 001-15925)).

     

    4.3

    Amended and Restated By-laws of Community Health Systems, Inc. (as of September 13, 2023) (incorporated by reference to Exhibit 3.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed September 13, 2023 (No. 001-15925)).

     

    5.1*

    Opinion of Bass, Berry & Sims PLC.

     

    23.1*

    Consent of Bass, Berry & Sims PLC (included in Exhibit 5.1).

     

    23.2*

    Consent of Deloitte & Touche LLP.

     

    24.1*

    Power of Attorney (included on signature page of this Registration Statement).

     

    99.1

    Community Health Systems, Inc. 2009 Stock Option and Award Plan, as amended and restated as of March 12, 2025 (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed May 14, 2025).

     

    107.1*

    Filing Fee Table.

     

    *Filed herewith

     

     

    Item 9. Undertakings.

    (a)

    The undersigned Registrant hereby undertakes:

    (1)

    To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

    (i)

    To include any prospectus required by Section 10(a)(3) of the Securities Act;

    (ii)

    To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective Registration Statement; and

    (iii)

    To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in this Registration Statement;

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the Registration Statement is on Form S-8 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.

    (2)

    That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (3)

    To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.


    (b)

    The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (c)

    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

     


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Franklin, State of Tennessee, on July 24, 2025.

    COMMUNITY HEALTH SYSTEMS, INC.

    (Registrant)

    By:

     /s/ Tim L. Hingtgen

      Tim L. Hingtgen

      Chief Executive Officer

    POWER OF ATTORNEY

    Each person whose signature appears below constitutes and appoints Tim L. Hingtgen, Kevin J. Hammons and Justin D. Pitt and each of them singly, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all (i) amendments (including post-effective amendments) and additions to this Registration Statement and (ii) any and all additional registration statements pursuant to Rule 462(b) of the Securities Act and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission (or any other governmental or regulatory authority), granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or either of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

    Name

    Title

    Date

    /s/ Tim L. Hingtgen

    Tim L. Hingtgen

     

    Chief Executive Officer and Director

    July 24, 2025

    /s/ Kevin J. Hammons

    Kevin J. Hammons

    President and Chief Financial Officer

    July 24, 2025

    /s/ Jason K. Johnson

    Jason K. Johnson

    Senior Vice President and Chief Accounting Officer

    July 24, 2025

     /s/ Wayne T. Smith

    Wayne T. Smith

     

    Chairman of the Board of Directors

    July 24, 2025

     /s/ Susan W. Brooks

    Susan W. Brooks

    Director

    July 24, 2025

     /s/ Ronald L. Burgess, Jr.

    Ronald L. Burgess, Jr.

    Director

    July 24, 2025

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     


    Name

     

    Title

     

    Date

     

     /s/ John A. Clerico

    John A. Clerico

    Director

    July 24, 2025

    /s/ Michael Dinkins

    Michael Dinkins

    Director

    July 24, 2025

    /s/ James S. Ely III

    James S. Ely III

     

    Director

    July 24, 2025

    /s/ John A. Fry

    John A. Fry

     

    Director

    July 24, 2025

    /s/ Joseph A. Hastings, D.M.D.

    Joseph A. Hastings, D.M.D.

    Director

    July 24, 2025

    /s/ Elizabeth T. Hirsch

    Elizabeth T. Hirsch

    Director

    July 24, 2025

    /s/ William Norris Jennings, M.D.

    William Norris Jennings, M.D.

    Director

    July 24, 2025

    /s/ K. Ranga Krishnan, MBBS

    K. Ranga Krishnan, MBBS

    Director

    July 24, 2025

    /s/ Fawn D. Lopez

    Fawn D. Lopez

     

    Director

    July 24, 2025

    /s/ H. James Williams, Ph.D.

    H. James Williams, Ph.D.

    Director

    July 24, 2025

     


    Get the next $CYH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CYH

    DatePrice TargetRatingAnalyst
    7/24/2025$3.00Buy → Hold
    Jefferies
    11/25/2024$5.00 → $2.50Equal Weight → Underweight
    Wells Fargo
    11/22/2024Mkt Perform → Underperform
    Raymond James
    3/6/2024$3.00Equal Weight
    Barclays
    6/17/2022$5.00Hold
    Loop Capital
    6/15/2022$7.50 → $5.50Buy → Neutral
    BofA Securities
    3/29/2022$12.00Equal Weight
    Wells Fargo
    1/10/2022$16.00 → $18.00Buy
    Citigroup
    More analyst ratings

    $CYH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Tim Hingtgen to Retire as Chief Executive Officer of Community Health Systems

      Kevin Hammons to Become Interim CEO and Jason Johnson to Become Interim CFO Community Health Systems, Inc. (the "Company") ("CHS") (NYSE:CYH) and its Board of Directors announced today that Tim Hingtgen will retire from his position as chief executive officer and as a member of the Board, effective September 30, 2025. It is anticipated that Hingtgen will enter into a consulting agreement in which he will continue to advise the Company's management team on issues related to healthcare operations and other Company matters. Kevin Hammons, who currently serves as president and chief financial officer, will assume the role of interim chief executive officer upon Hingtgen's retirement, and Ja

      7/23/25 4:16:00 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Community Health Systems, Inc. Announces Second Quarter Ended June 30, 2025 Results

      Community Health Systems, Inc. (NYSE:CYH) (the "Company") today announced financial and operating results for the three and six months ended June 30, 2025. The following highlights the financial and operating results for the three months ended June 30, 2025. Net operating revenues totaled $3.133 billion. Net income attributable to Community Health Systems, Inc. stockholders was $282 million, or $2.09 per share (diluted), compared to net loss of $(13) million, or $(0.10) per share (diluted), for the same period in 2024. Excluding the adjusting items as presented in the table in footnote (e) on page 15, net loss attributable to Community Health Systems, Inc. stockholders was $(0.05) p

      7/23/25 4:15:00 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

      Agreement aims to provide broader access to testing and laboratory services to communities across the U.S. Community Health Systems, Inc. (Company) (NYSE:CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a definitive agreement with Labcorp (NYSE:LH), pursuant to which Labcorp will acquire select assets and assume certain leases of the ambulatory outreach laboratory services of CHS health systems in 13 states, including certain patient service centers and in-office phlebotomy locations, for $195 million cash. When the transaction is complete, CHS patients and providers will benefit from broader access to Labcorp's comprehensive testing a

      7/22/25 4:15:00 PM ET
      $CYH
      $LH
      Hospital/Nursing Management
      Health Care
      Medical Specialities

    $CYH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Community Health downgraded by Jefferies with a new price target

      Jefferies downgraded Community Health from Buy to Hold and set a new price target of $3.00

      7/24/25 7:25:45 AM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Community Health downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded Community Health from Equal Weight to Underweight and set a new price target of $2.50 from $5.00 previously

      11/25/24 7:40:37 AM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Community Health downgraded by Raymond James

      Raymond James downgraded Community Health from Mkt Perform to Underperform

      11/22/24 7:42:43 AM ET
      $CYH
      Hospital/Nursing Management
      Health Care

    $CYH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Brooks Susan W converted options into 5,894 shares, increasing direct ownership by 11% to 58,100 units (SEC Form 4)

      4 - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Issuer)

      6/2/25 4:36:16 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • CEO Hingtgen Tim converted options into 33,600 shares, was granted 200,000 shares and covered exercise/tax liability with 78,807 shares, increasing direct ownership by 13% to 1,388,781 units (SEC Form 4)

      4 - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Issuer)

      3/3/25 6:06:04 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Regional President Medley Mark B converted options into 10,500 shares, was granted 25,000 shares and covered exercise/tax liability with 15,682 shares, increasing direct ownership by 18% to 128,637 units (SEC Form 4)

      4 - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Issuer)

      3/3/25 6:05:42 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care

    $CYH
    SEC Filings

    See more
    • SEC Form S-8 filed by Community Health Systems Inc.

      S-8 - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Filer)

      7/24/25 5:03:02 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • SEC Form 10-Q filed by Community Health Systems Inc.

      10-Q - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Filer)

      7/24/25 4:22:47 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Community Health Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Filer)

      7/23/25 4:18:04 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care

    $CYH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Smith Wayne T bought $2,110,000 worth of shares (1,000,000 units at $2.11), increasing direct ownership by 24% to 5,107,901 units (SEC Form 4)

      4 - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Issuer)

      11/1/23 4:17:23 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care

    $CYH
    Leadership Updates

    Live Leadership Updates

    See more
    • Tim Hingtgen to Retire as Chief Executive Officer of Community Health Systems

      Kevin Hammons to Become Interim CEO and Jason Johnson to Become Interim CFO Community Health Systems, Inc. (the "Company") ("CHS") (NYSE:CYH) and its Board of Directors announced today that Tim Hingtgen will retire from his position as chief executive officer and as a member of the Board, effective September 30, 2025. It is anticipated that Hingtgen will enter into a consulting agreement in which he will continue to advise the Company's management team on issues related to healthcare operations and other Company matters. Kevin Hammons, who currently serves as president and chief financial officer, will assume the role of interim chief executive officer upon Hingtgen's retirement, and Ja

      7/23/25 4:16:00 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Quanex Building Products Appoints Manish Shah and Amit Singhi to Board of Directors

      HOUSTON, TEXAS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- August 12, 2024 – Quanex Building Products Corporation (NYSE:NX) ("Quanex" or the "Company") today announced the appointment of Manish H. Shah and Amit Singhi to its Board of Directors effective August 12, 2024. George Wilson, President and Chief Executive Officer, commented, "Manish and Amit are both proven, forward-thinking leaders, and we're looking forward to the insights they'll bring to Quanex as we continuously strengthen our focus on profitable growth across all areas of the Company.  We're confident in the value of their unique perspectives, and our leadership team is looking forward to their contributions." Mr. Shah is the C

      8/12/24 4:15:00 PM ET
      $CYH
      $F
      $NOW
      $NX
      Hospital/Nursing Management
      Health Care
      Auto Manufacturing
      Consumer Discretionary
    • Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, Dec. 1, 2023 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from t

      12/1/23 6:16:00 PM ET
      $ALK
      $ALKS
      $AWI
      $BLDR
      Air Freight/Delivery Services
      Consumer Discretionary
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $CYH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Community Health Systems Inc.

      SC 13G/A - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Subject)

      11/14/24 5:52:10 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Community Health Systems Inc.

      SC 13G/A - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Subject)

      11/14/24 4:11:11 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by Community Health Systems Inc.

      SC 13G - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Subject)

      11/13/24 9:31:30 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care

    $CYH
    Financials

    Live finance-specific insights

    See more
    • Community Health Systems, Inc. Announces Second Quarter Ended June 30, 2025 Results

      Community Health Systems, Inc. (NYSE:CYH) (the "Company") today announced financial and operating results for the three and six months ended June 30, 2025. The following highlights the financial and operating results for the three months ended June 30, 2025. Net operating revenues totaled $3.133 billion. Net income attributable to Community Health Systems, Inc. stockholders was $282 million, or $2.09 per share (diluted), compared to net loss of $(13) million, or $(0.10) per share (diluted), for the same period in 2024. Excluding the adjusting items as presented in the table in footnote (e) on page 15, net loss attributable to Community Health Systems, Inc. stockholders was $(0.05) p

      7/23/25 4:15:00 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Community Health Systems to Webcast Second Quarter 2025 Conference Call

      Community Health Systems, Inc. (NYSE:CYH) today announced that it will webcast its second quarter 2025 conference call. The Company will issue a press release announcing its results on Wednesday, July 23, 2025, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on Thursday, July 24, 2025. During this call, Community Health Systems will review the Company's financial and operating results for the second quarter ended June 30, 2025. A live webcast of the conference call will be available online at https://www.chs.net/investor-relations/investor-tools/webcasts/. An online replay will follow shortly after the ca

      7/9/25 11:00:00 AM ET
      $CYH
      Hospital/Nursing Management
      Health Care
    • Community Health Systems, Inc. Announces First Quarter Ended March 31, 2025 Results

      Community Health Systems, Inc. (NYSE:CYH) (the "Company") today announced financial and operating results for the three months ended March 31, 2025. The following highlights the financial and operating results for the three months ended March 31, 2025. Net operating revenues totaled $3.159 billion. Net loss attributable to Community Health Systems, Inc. stockholders was $(13) million, or $(0.10) per share (diluted), compared to $(41) million, or $(0.32) per share (diluted), for the same period in 2024. Excluding the adjusting items as presented in the table in footnote (e) on page 12, net loss attributable to Community Health Systems, Inc. stockholders was $(0.03) per share (diluted),

      4/23/25 4:15:00 PM ET
      $CYH
      Hospital/Nursing Management
      Health Care